TrialNeurology2026

Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.

Karen E Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.